Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
APO-TEP: Continuous Apomorphine Infusion in Parkinson's Disease
NCT01039090Phase 3Completed
- Sponsor
- CHU Rennes
- Start
- Feb 2009
- Primary completion
- Feb 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of apomorphine in Parkinson's disease (PD), sponsored by CHU Rennes. Started Feb 2009; status: completed.
02
Drugs
apomorphine
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT01039090.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01039090.